Experimental AML combo trial halted early – what happened?
Disease control
Terminated
This early-phase trial tested an experimental drug called CWP232291 combined with the standard chemotherapy cytarabine in 15 adults with acute myeloid leukemia (AML) that had returned or not responded to prior treatments. The study aimed to find a safe dose and check for signs of…
Phase: PHASE1, PHASE2 • Sponsor: JW Pharmaceutical • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC